(Q74615754)
Statements
Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels (English)
G Batist
F Patenaude
P Champagne
D Croteau
C Levinton
C Hariton
B Escudier
scientific article published on 01 August 2002
No description defined